Clinical Trial Update: THINC-it Vortioxetine - Sensitivity to Change [Phase 2, Phase 3]

View source ↗

Summary

This entry reports results from Phase 2 and Phase 3 trials of vortioxetine evaluating sensitivity to cognitive change in adults with Major Depressive Disorder; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Brain and Cognition Discovery Foundation | Conditions: Major Depressive Disorder, Cognitive Change | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-01-20